Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — H1 FY2025 Earnings Presentation
28 slides from Nath Bio-genes (india)'s earnings presentation, Oct 23, 2024
Slide 1: Exchange filing cover letter
23rd October 2024 The Manager-Listing The Manager- Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 NSE Code-NATHBIOGEN Dear Sir/Madam, Subject- Presentation
Slide 2: Investor Presentation – Q2 & H1FY25
Investor Presentation – Q2 & H1FY25 Website www.nathbiogenes.com 1
Slide 3: Disclaimer
Disclaimer Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual
Slide 4: Competitive Positioning in a Tough Sector
Competitive Positioning in a Tough Sector Focus Area Winning Strategies Product Selection • Focus on Cotton, Wheat, Maize & Fodder Bajra • Build a dream-product basket with superior • Empower Stakeholders; Build long-term, loyal, and diversified products symbiotic relationships with our production •
Slide 5: What our Business Delivered in Last 7 Years
What our Business Delivered in Last 7 Years Average Selling Price (Rs/kg) is Increasing Revenue Growth (INR Cr) 1,311 CAGR 10% 333 192 480 209 128 FY18 FY24 FY18 FY24 Field Crops Vegetables 4
Slide 6: Tailor Made Products
2 Tailor Made Products & Understand key Develop products Focus on disease farmer requirements to suit various and pest resistance based on deep agri climatic which automatically market research. conditions results in higher yield
Slide 7: Focused on R&D
Focused on R&D Well Invested, DSIR recognized R&D Innovation Centers Nath Bio-Genes (India) Limited 6
Slide 8: Focused on Shareholder Value Creation
Focused on Shareholder Value Creation Product Differentiated Margin Expansion Growing Business Excellence Customer Growing EBITDA Strong Positions in Innovation and solution Experience margins through important crops that drive productivity efficient operations Expanding market reach and create valu
Slide 9: Farming Community’s Testimonials
Farming Community’s Testimonials 8
Slide 10: Farmers on Khushi-27 Se
Farmers on Khushi-27 Se aMel eet egetl-27 Va cecelot fest e fiecht sun eft reeced é He tract eff afean ed wafer é | duno egett-27 a wot eige € | - dotlelails Og (PreTT)
Slide 11: Farmers on Golden-72
Farmers on Golden-72 od (rer ener mies 72 8 aR afeyy Juni feet 21 Bab clot sade otee wT th lat F ast arated aft 3a fei | € aims Ue afeaT eat el - Hera Wear, aicTrest (3ifSerr) ) GOLDEN-72 NATH PADDY SEEDS Nath Bio-Genes (India) Limited 10
Slide 12: Farmers on Super-27
Farmers on Super-27 eo NATH seeps? mel Gael GUe-27 Het Vecih ele é | Te gen et Sear aisrel fewest 2) sere ast JOH at Haeced leicht ete eet Ft rer at Oat Ge Seer Wacare Etat e | | | - Blcettcr, faci: spTer (Iaevce!) NaTH Seep SUPER-27 (NBBH-27) NATH HYBRID BAJRA SEEDS
Slide 13: Farmers on Alexander
—— #2 + < Sak Farmers on Alexander ie oneal feleten ferd-3iciesise Up sdeced fest €1 Beith thet sendy ee el sie creat Ufeaent fore aft TE 6] asl Ser feat cht afeen Tos fect e ne ALEXANDER 12
Slide 14: Farmers on NCH-2561
Farmers on NCH-2561 Ry Hot onal fate Lot ett Pa-2561 CMMs eft te del dec et EBT HOTS PETE! Se Nee Ee ON wh MrdH were sie unolne eo Ged cel ela | tearaoT 2 Gel sa feat & gen et alee sum leicht 21 = Tle 7PTAY, eile, Fic: Tetoil (ceTeTE) NCH-2561 13
Slide 15: Testimonials: Nath Sanket
| Testimonials: Nath Sanket ~ $2 3) red iN oa ‘ae! Hebd Ae Veo Haeaed HUET Vac 21 wa ead dt Ae TATer Just ect eI foe ed VT & ofa wectefict alot & wrevr carseat wT waufeedcar.. ey . NBC 1111 BG Il Cotton Hye Seeds with Bogard Technology
Slide 16: Farmers on “Super-27”
Farmers on “Super-27” ‘Bel WT Tate FUe-27 Vw Teeaed ase 2. serb fale ole vd asigd @ ste sus aft Haeaed facta &. Jom w emer are & fare aft TerHsgM WME... 19
Slide 17: Testimonials: Akhand
a Testimonials: Akhand > | Farmers on “Akhand” onal tht feds UH aedetot cace VsMctt , fied her sare Tee ect ST th eld e. hel Be Ud agg Aol h orev wes Ufeceot hee sugw e site sus ever aft Faved e. AKHAND (nt#-1912) a
Slide 18: Q2 & H1FY25 Performance
Q2 & H1FY25 PERFORMANCE 17
Slide 19: Key Business Highlights
Key Business Highlights • Cotton Value increased by 10.59% • Paddy Volume decrease by 4.5% but value wise increased by 5.4% highlighting company’s efforts on hybrid paddy. Crop Performance • Maize value surged by 35.18%, while bajra value increased by 7.6%. • Total field crop volume grew by 2.3%, wi
Slide 20: Key Financial Highlights – H1FY25
Key Financial Highlights – H1FY25 • Incremental Revenue growth of INR 182 Mn YoY Financial Performance • Gross Margin maintained at 50% • EBITDA also maintained. • Net Profit increased by 5% to INR 365 Mn 19
Slide 21: Segmental Revenue Contribution
Segmental Revenue Contribution H1FY25 Revenue H1FY24 Revenue INR 2,761 Mn INR 2,578 Mn Cotton Cotton, 30% 32% Others, Others 39% 45% Paddy 25% Paddy, 29% Cotton Paddy Others Cotton Paddy Others • Others include: Jowar, Bajra, Maize, Mustard, Wheat 20
Slide 22: Income Statement
Income Statement Particulars (INR Mn) H1FY25 H1FY24 %Change (YoY) Total Revenue 2,761 2,578 7% Gross Profit 1,407 1,309 7% Gross Margin (%) 51% 50% EBITDA 434 421 3% EBITDA Margin (%) 16% 16% Depreciation 17 15 9% Finance Cost 52 52 Other Income 2 2 15% PBT 368 356 3% Tax 1 6 Tax Rate (%) 0.2% 1.6%
Slide 23: Appendix
oe oy NATH seeps APPENDIX Nath Bio-Genes (India) Limited
Slide 24: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet Net Debt (INR Mn) Net Worth (INR Mn) 6,133 6,107 5,576 5,734 888 5,420 5,076 4,692 679 659 672 576 478 3,033 363 328 207 1,071 1,213 -121 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 EBITDA Margin
Slide 25: Attracting the Best Talent
Visionary fe Attracting the Best Talent Mr. Nandkishor Kagliwal Mr. Satish Kagliwal Chairman Managing Director Leadership Team Capt (Dr.) Devinder Khurana Dr. S. K. Raina Dr. V.N. Kulkarni Mr. K. Reddy CFO Head-Genetic Research Head-R & D Head-Supply Chain Nath Promoters are committed to sustainable
Slide 26: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY24 FY23 FY22 FY21 FY20 Total Revenue 3,326 3,013 2,783 3,076 2,799 Gross Profit 1,991 1,667 1,544 1,715 1,536 Gross Margin (%) 60% 55% 56% 56% 55% EBITDA 504 489 373 667 547 EBITDA Margin (%) 15% 16% 13% 22% 20% Depreci
Slide 27: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn) FY24 FY23 FY22 FY21 FY20 Liabilities (INR Mn) FY24 FY23 FY22 FY21 FY20 Fixed Assets 2,406 2,340 2,329 2,333 2,308 Share Capital 190 190 190 190 190 Other Intangible 88 104 120 136 152 Assets Financial Assets 61 51 51 53 52 Reserves & Surplus 5,917 5,544 5,230
Slide 28: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja sheetal@GoIndiaadvisors.com M:+91 97693 64166 Deepika Sharma deepika@GoIndiaadvisors.com M:+918451029510 27
Nath Bio-Genes (India) — H1 FY2025 Earnings Presentation on 6ix